Ladenburg Thalmann Financial Services’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $60K | Buy |
2,579
+1,862
| +260% | +$43.3K | ﹤0.01% | 3387 |
|
|
2019
Q3 | $13K | Buy |
717
+357
| +99% | +$6.47K | ﹤0.01% | 4261 |
|
|
2019
Q2 | $6K | Sell |
360
-622
| -63% | -$10.4K | ﹤0.01% | 4639 |
|
|
2019
Q1 | $23K | Buy |
982
+628
| +177% | +$14.7K | ﹤0.01% | 3910 |
|
|
2018
Q4 | $9K | Sell |
354
-127
| -26% | -$3.23K | ﹤0.01% | 4336 |
|
|
2018
Q3 | $15K | Sell |
481
-211
| -30% | -$6.58K | ﹤0.01% | 4064 |
|
|
2018
Q2 | $19K | Hold |
692
| – | – | ﹤0.01% | 3855 |
|
|
2018
Q1 | $19K | Sell |
692
-3,345
| -83% | -$91.8K | ﹤0.01% | 3855 |
|
|
2017
Q4 | $73K | Hold |
4,037
| – | – | ﹤0.01% | 2957 |
|
|
2017
Q3 | $65K | Hold |
4,037
| – | – | ﹤0.01% | 2911 |
|
|
2017
Q2 | $56K | Buy |
4,037
+37
| +0.9% | +$513 | ﹤0.01% | 2942 |
|
|
2017
Q1 | $60K | Buy |
4,000
+3,500
| +700% | +$52.5K | ﹤0.01% | 2779 |
|
|
2016
Q4 | $7K | Sell |
500
-500
| -50% | -$7K | ﹤0.01% | 4071 |
|
|
2016
Q3 | $17K | Buy |
1,000
+500
| +100% | +$8.5K | ﹤0.01% | 3496 |
|
|
2016
Q2 | $9K | Hold |
500
| – | – | ﹤0.01% | 3835 |
|
|
2016
Q1 | $9K | Hold |
500
| – | – | ﹤0.01% | 3757 |
|
|
2015
Q4 | $13K | Hold |
500
| – | – | ﹤0.01% | 3515 |
|
|
2015
Q3 | $12K | Hold |
500
| – | – | ﹤0.01% | 3416 |
|
|
2015
Q2 | $16K | Buy |
+500
| New | +$16K | ﹤0.01% | 3382 |
|